PDCD1 and neoplasm: The tumor growth was significantly inhibited after administration of cisplatin plus anti-PD1 antibody, while cisplatin or PD1 antibody monotherapy showed a moderate anti-tumor efficacy (Figures 5A,B, Supplementary Figures S3A,B).